Combigene AB
COMBI | ST
Overview
Corporate Details
- ISIN(s):
- SE0016101935
- LEI:
- 213800CITFPHX4TL8G93
- Country:
- Sweden
- Address:
- Agavägen 52A, 181 55 Lidingö
- Website:
- https://combigene.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Combigene AB is a Swedish gene therapy company focused on neurological and metabolic diseases. Its therapies aim to address conditions with high unmet needs.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Kancera | Sweden | KAN | |
|
Kuros Biosciences Ltd. | Switzerland | KURN | |
|
Lidds AB | Sweden | LIDDS | |
|
Lifecare ASA | Norway | LIFE | |
|
Lineage Cell Therapeutics Inc. | Israel | LCTX | |
|
Lipidor AB | Sweden | LIPI | |
|
Lipigon Pharmaceuticals AB | Sweden | LPGO | |
|
Lipum AB | Sweden | LIPUM | |
|
Lonza Group AG | Switzerland | LONN | |
|
LYSOGENE | France | LYS |